Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination.
Hast BE, Cloer EW, Goldfarb D, Li H, Siesser PF, Yan F, Walter V, Zheng N, Hayes DN, Major MB.
Hast BE, et al. Among authors: major mb.
Cancer Res. 2014 Feb 1;74(3):808-17. doi: 10.1158/0008-5472.CAN-13-1655. Epub 2013 Dec 9.
Cancer Res. 2014.
PMID: 24322982
Free PMC article.